BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
3.120
-0.410 (-11.61%)
At close: Jun 13, 2025, 4:00 PM
3.179
+0.059 (1.89%)
After-hours: Jun 13, 2025, 7:57 PM EDT
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $21.87 million as of June 13, 2025. Its market cap has decreased by -0.13% in one year.
Market Cap
21.87M
Enterprise Value
16.14M
1-Year Change
-0.13%
Ranking
Category
Stock Price
$3.12
Market Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has decreased from $26.00M to $21.87M, a decrease of -15.88%. That is a compound annual growth rate of -3.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2025 | 13.10M | -47.60% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 726.72B |
| Johnson & Johnson | 375.78B |
| Novo Nordisk | 353.21B |
| AbbVie | 338.21B |
| UnitedHealth Group | 288.21B |
| Abbott Laboratories | 236.37B |
| Novartis AG | 231.84B |
| AstraZeneca | 229.07B |